Device type · QYI
Ablation Catheter, Renal Denervation
Last checked: Nov 19, 2026Source: openFDAMethods & limitations
Product code
QYI
Cardiovascular
Device class
Class III
FDA decisions since 2015
2
510(k), De Novo and PMA
Adverse event reports
22
Received Nov 1, 2025 to Nov 19, 2026
How FDA classifies it
- Device type
- Ablation Catheter, Renal Denervation
- Product code
- QYI
- Device class
- Class III
- Review panel
- Cardiovascular
- Specialty
- Cardiology, Electrophysiology
- FDA record
- Classification database entry for QYI
Latest FDA decisions
- Symplicity Spyral Renal Denervation SystemBreakthroughPMA
P220026 · Decided Nov 17, 2023 · 374 days after receipt
Device type: Ablation catheter, renal denervation (QYI) · Cardiology
- Paradise® Ultrasound Renal Denervation SystemBreakthroughPMA
P220023 · Decided Nov 7, 2023 · 378 days after receipt
Device type: Ablation catheter, renal denervation (QYI) · Cardiology
Reports received
22
Received Nov 1, 2025 to Nov 19, 2026
Malfunction reports
8
36% of reports
Injury reports
14
64% of reports
Death reports
0
0.0% of reports
Adverse event reports received per month
By the date FDA received each report, stacked by event type. The newest month is incomplete.
- Malfunction
- Injury
- Death
- Other
View as table
| Month | Malfunction | Injury | Death | Other |
|---|---|---|---|---|
| Dec 23 | 0 | 0 | 0 | 0 |
| Jan 24 | 0 | 0 | 0 | 0 |
| Feb 24 | 0 | 0 | 0 | 0 |
| Mar 24 | 0 | 0 | 0 | 0 |
| Apr 24 | 0 | 2 | 0 | 0 |
| May 24 | 0 | 0 | 0 | 0 |
| Jun 24 | 0 | 0 | 0 | 0 |
| Jul 24 | 1 | 0 | 0 | 0 |
| Aug 24 | 0 | 3 | 0 | 1 |
| Sep 24 | 0 | 1 | 0 | 0 |
| Oct 24 | 1 | 4 | 0 | 0 |
| Nov 24 | 0 | 2 | 0 | 0 |
| Dec 24 | 0 | 2 | 0 | 0 |
| Jan 25 | 0 | 1 | 0 | 0 |
| Feb 25 | 0 | 0 | 0 | 0 |
| Mar 25 | 0 | 1 | 0 | 0 |
| Apr 25 | 0 | 0 | 0 | 0 |
| May 25 | 0 | 1 | 0 | 0 |
| Jun 25 | 3 | 0 | 0 | 0 |
| Jul 25 | 0 | 1 | 0 | 0 |
| Aug 25 | 0 | 0 | 0 | 0 |
| Sep 25 | 0 | 1 | 0 | 0 |
| Oct 25 | 0 | 0 | 0 | 0 |
| Nov 25 | 0 | 3 | 0 | 0 |
| Dec 25 | 3 | 1 | 0 | 0 |
| Jan 26 | 0 | 0 | 0 | 0 |
| Feb 26 | 0 | 1 | 0 | 0 |
| Mar 26 | 1 | 0 | 0 | 0 |
| Apr 26 | 2 | 1 | 0 | 0 |
| May 26 | 0 | 0 | 0 | 0 |
| Jun 26 | 1 | 1 | 0 | 0 |
| Jul 26 | 1 | 1 | 0 | 0 |
| Aug 26 | 0 | 5 | 0 | 0 |
| Sep 26 | 0 | 0 | 0 | 0 |
| Oct 26 | 0 | 1 | 0 | 0 |
| Nov 26 | 0 | 0 | 0 | 0 |
Manufacturers named most often
Last 12 months. Bigger sellers get more reports. This is not a ranking of safety.
Device problems as coded
Last 12 months. FDA's terms. A report can carry several.
- Adverse Event Without Identified Device or Use Problem9
- Difficult to Insert4
- Expiration Date Error4
7 more in this ranking with a free account
Patient problems as coded
Last 12 months. FDA's terms. A report can carry several.
- No Clinical Signs, Symptoms or Conditions8
- Vascular Dissection4
- Bradycardia3
7 more in this ranking with a free account
Recent recalls
From FDA's recall database. FDA lists each recalled product separately, so one recall can appear several times. A recall is often a correction or a labeling change, not a removal from the market.
Z-1654-2026 · Started Jan 29, 2026 · Posted by FDA Mar 27, 2026
Reason given: Due to firm distributing a nonconforming product that supposed to be scrapped and not for human use.
Cause as FDA categorized it: Under Investigation by firm
Z-1655-2026 · Started Jan 29, 2026 · Posted by FDA Mar 27, 2026
Reason given: Due to firm distributing a nonconforming product that supposed to be scrapped and not for human use.
Cause as FDA categorized it: Under Investigation by firm
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.